IFC Advisory is delighted to be working with Midatech Pharma (LSE AIM: MTPH; NASDAQ: MTP) Midatech is an R&D company focused on delivering innovative oncology and rare disease products to patients. The Company is developing a range of improved chemo-therapeutics or new immuno-therapeutics, using its three-proprietary platform drug delivery technologies, all of which are in the clinic.
Client Appointment
Midatech Pharma Appointment
22
Mar
Mar
Yew Grove REIT Appoints IFC Advisory
Financial PR and Investor Relations advisory firm, IFC Advisory is delighted to announce that it [...]
Apr
Midatech Pharma Appointment
IFC Advisory is delighted to be working with Midatech Pharma (LSE AIM: MTPH; NASDAQ: MTP) [...]
Mar
ECO Animal Health Group plc Appointment
IFC Advisory is delighted to be working with Eco Animal Health Group plc ECO Animal [...]
Feb